We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

82 hedge funds and large institutions have $179M invested in VanEck Biotech ETF in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more call options, than puts

Call options by funds: $1.48M | Put options by funds: $911K

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

4% more funds holding

Funds holding: 79 → 82 (+3)

8% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 24

8.02% less ownership

Funds ownership: 34.65% → 26.63% (-8%)

28% less capital invested

Capital invested by funds: $249M → $179M (-$69.4M)

Holders
82
Holders Change
+3
Holders Change %
+3.8%
% of All Funds
1.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
22
Reduced
24
Closed
11
Calls
$1.48M
Puts
$911K
Net Calls
+$572K
Net Calls Change
-$2.84M

Top Buyers

1
CG
Colony Group
Massachusetts
+$5.02M
2
TC
Trust Company
Kansas
+$4.39M
3
WI
WBI Investments
New Jersey
+$2.67M
4
OLA
Oliver Luxxe Assets
New Jersey
+$1.61M
5
ECM
Endurant Capital Management
California
+$1.42M

Top Sellers

1
AllianceBernstein
AllianceBernstein
Tennessee
-$51.7M
2
UBS Group
UBS Group
Switzerland
-$13.7M
3
Creative Planning
Creative Planning
Kansas
-$2.42M
4
AL
Aspiriant LLC
California
-$2.13M
5
PAG
Private Advisor Group
New Jersey
-$1.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
1
AllianceBernstein
Tennessee
$77.8M -$51.7M -404,886 -39%
Morgan Stanley
2
Morgan Stanley
New York
$11.9M +$1.1M +8,609 +10%
UBS Group
3
UBS Group
Switzerland
$9.29M -$13.7M -107,560 -59%
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$6.53M -$969K -7,585 -13%
ECM
5
Endurant Capital Management
California
$6.22M +$1.42M +11,100 +29%
MCM
6
Murphy Capital Management
New Jersey
$5.86M -$133K -1,043 -2%
CG
7
Colony Group
Massachusetts
$4.9M +$5.02M +39,318 New
TC
8
Trust Company
Kansas
$4.33M +$4.39M +34,357 +8,084%
SFS
9
Strategic Financial Services
New York
$3.39M +$7.66K +60 +0.2%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$2.81M +$221K +1,728 +8%
Bank of America
11
Bank of America
North Carolina
$2.61M +$530K +4,152 +25%
WI
12
WBI Investments
New Jersey
$2.61M +$2.67M +20,934 New
SB
13
Suntrust Banks
Georgia
$2.43M +$146K +1,145 +6%
RJA
14
Raymond James & Associates
Florida
$2.3M -$46.6K -365 -2%
BRM
15
Boston Research & Management
Massachusetts
$2.13M -$623K -4,875 -22%
Stifel Financial
16
Stifel Financial
Missouri
$1.9M -$3.7K -29 -0.2%
HighTower Advisors
17
HighTower Advisors
Illinois
$1.79M +$85.2K +667 +5%
MJRIC
18
Mogy Joel R Investment Counsel
California
$1.76M +$1.22M +9,525 +208%
Commonwealth Equity Services
19
Commonwealth Equity Services
Massachusetts
$1.63M -$27.8K -218 -2%
LPL Financial
20
LPL Financial
California
$1.58M -$154K -1,202 -9%
OLA
21
Oliver Luxxe Assets
New Jersey
$1.57M +$1.61M +12,623 New
AFG
22
Albion Financial Group
Utah
$1.4M -$82.2K -644 -5%
ACM
23
Aviance Capital Management
Florida
$1.4M -$245K -1,921 -15%
RJFSA
24
Raymond James Financial Services Advisors
Florida
$1.36M +$848K +6,643 +155%
VF
25
Virtu Financial
New York
$1.34M +$1.37M +10,746 New
1
2 3 4

BBH Hedge Fund Activity: Q4 2017 in Review

82 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2017, worth a combined $179M — down 28% from $249M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new BBH positions and 11 closed out — a net gain of 3 holders — while 22 added to existing stakes and 24 trimmed.

The largest buyer was Colony Group, opening a new position worth an estimated $5.02M. The largest seller was AllianceBernstein, cutting an estimated $51.7M.

  • 82 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2017, up from 79 in Q3 2017.
  • Funds reported $179M of VanEck Biotech ETF stock for Q4 2017, down 28% quarter-over-quarter.
  • 14 funds opened new VanEck Biotech ETF positions in Q4 2017 and 11 closed out, a net change of +3 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2017 was Colony Group, an estimated $5.02M added.
  • The largest VanEck Biotech ETF seller in Q4 2017 was AllianceBernstein, an estimated $51.7M sold.

Based on aggregated 13F filings for Q4 2017.